Molecular investigations to improve diagnostic accuracy in patients with ARC syndrome.

Andrew R. Cullinane, Anna Straatman-Iwanowska, Jeong K. Seo, Jae S. Ko, Kyung S. Song, Maria Gizewska, Dariusz Gruszfeld, Dorota Gliwicz, Beyhan Tuysuz, Gulin Erdemir, Rachid Sougrat, Yoshiyuki Wakabayashi, Rupert Hinds, Angela Barnicoat, Hanna Mandel, David Chitayat, Björn Fischler, Angels Garcia-Cazorla, A. S. Knisely, Deirdre A. Kelly & 2 others Eamonn R. Maher, Paul Gissen

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Arthrogryposis, Renal dysfunction and Cholestasis (ARC) syndrome is a multi-system autosomal recessive disorder caused by germline mutations in VPS33B. The detection of germline VPS33B mutations removes the need for diagnostic organ biopsies (these carry a>50% risk of life-threatening haemorrhage due to platelet dysfunction); however, VPS33B mutations are not detectable in approximately 25% of patients. In order further to define the molecular basis of ARC we performed mutation analysis and mRNA and protein studies in patients with a clinical diagnosis of ARC. Here we report novel mutations in VPS33B in patients from Eastern Europe and South East Asia. One of the mutations was present in 7 unrelated Korean patients. Reduced expression of VPS33B and cellular phenotype was detected in fibroblasts from patients clinically diagnosed with ARC with and without known VPS33B mutations. One mutation-negative patient was found to have normal mRNA and protein levels. This patient's clinical condition improved and he is alive at the age of 2.5 years. Thus we show that all patients with a classical clinical course of ARC had decreased expression of VPS33B whereas normal VPS33B expression was associated with good prognosis despite initial diagnosis of ARC. (c) 2008 Wiley-Liss, Inc.

Original languageEnglish
JournalHuman Mutation
Volume30
Issue number2
DOIs
Publication statusPublished - 1 Feb 2009

Cite this

Cullinane, A. R., Straatman-Iwanowska, A., Seo, J. K., Ko, J. S., Song, K. S., Gizewska, M., ... Gissen, P. (2009). Molecular investigations to improve diagnostic accuracy in patients with ARC syndrome. Human Mutation, 30(2). https://doi.org/10.1002/humu.20900
Cullinane, Andrew R. ; Straatman-Iwanowska, Anna ; Seo, Jeong K. ; Ko, Jae S. ; Song, Kyung S. ; Gizewska, Maria ; Gruszfeld, Dariusz ; Gliwicz, Dorota ; Tuysuz, Beyhan ; Erdemir, Gulin ; Sougrat, Rachid ; Wakabayashi, Yoshiyuki ; Hinds, Rupert ; Barnicoat, Angela ; Mandel, Hanna ; Chitayat, David ; Fischler, Björn ; Garcia-Cazorla, Angels ; Knisely, A. S. ; Kelly, Deirdre A. ; Maher, Eamonn R. ; Gissen, Paul. / Molecular investigations to improve diagnostic accuracy in patients with ARC syndrome. In: Human Mutation. 2009 ; Vol. 30, No. 2.
@article{a23c2b7d1b93459a876d47ddecd1da8f,
title = "Molecular investigations to improve diagnostic accuracy in patients with ARC syndrome.",
abstract = "Arthrogryposis, Renal dysfunction and Cholestasis (ARC) syndrome is a multi-system autosomal recessive disorder caused by germline mutations in VPS33B. The detection of germline VPS33B mutations removes the need for diagnostic organ biopsies (these carry a>50{\%} risk of life-threatening haemorrhage due to platelet dysfunction); however, VPS33B mutations are not detectable in approximately 25{\%} of patients. In order further to define the molecular basis of ARC we performed mutation analysis and mRNA and protein studies in patients with a clinical diagnosis of ARC. Here we report novel mutations in VPS33B in patients from Eastern Europe and South East Asia. One of the mutations was present in 7 unrelated Korean patients. Reduced expression of VPS33B and cellular phenotype was detected in fibroblasts from patients clinically diagnosed with ARC with and without known VPS33B mutations. One mutation-negative patient was found to have normal mRNA and protein levels. This patient's clinical condition improved and he is alive at the age of 2.5 years. Thus we show that all patients with a classical clinical course of ARC had decreased expression of VPS33B whereas normal VPS33B expression was associated with good prognosis despite initial diagnosis of ARC. (c) 2008 Wiley-Liss, Inc.",
author = "Cullinane, {Andrew R.} and Anna Straatman-Iwanowska and Seo, {Jeong K.} and Ko, {Jae S.} and Song, {Kyung S.} and Maria Gizewska and Dariusz Gruszfeld and Dorota Gliwicz and Beyhan Tuysuz and Gulin Erdemir and Rachid Sougrat and Yoshiyuki Wakabayashi and Rupert Hinds and Angela Barnicoat and Hanna Mandel and David Chitayat and Bj{\"o}rn Fischler and Angels Garcia-Cazorla and Knisely, {A. S.} and Kelly, {Deirdre A.} and Maher, {Eamonn R.} and Paul Gissen",
year = "2009",
month = "2",
day = "1",
doi = "10.1002/humu.20900",
language = "English",
volume = "30",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "Wiley-Blackwell",
number = "2",

}

Cullinane, AR, Straatman-Iwanowska, A, Seo, JK, Ko, JS, Song, KS, Gizewska, M, Gruszfeld, D, Gliwicz, D, Tuysuz, B, Erdemir, G, Sougrat, R, Wakabayashi, Y, Hinds, R, Barnicoat, A, Mandel, H, Chitayat, D, Fischler, B, Garcia-Cazorla, A, Knisely, AS, Kelly, DA, Maher, ER & Gissen, P 2009, 'Molecular investigations to improve diagnostic accuracy in patients with ARC syndrome.' Human Mutation, vol. 30, no. 2. https://doi.org/10.1002/humu.20900

Molecular investigations to improve diagnostic accuracy in patients with ARC syndrome. / Cullinane, Andrew R.; Straatman-Iwanowska, Anna; Seo, Jeong K.; Ko, Jae S.; Song, Kyung S.; Gizewska, Maria; Gruszfeld, Dariusz; Gliwicz, Dorota; Tuysuz, Beyhan; Erdemir, Gulin; Sougrat, Rachid; Wakabayashi, Yoshiyuki; Hinds, Rupert; Barnicoat, Angela; Mandel, Hanna; Chitayat, David; Fischler, Björn; Garcia-Cazorla, Angels; Knisely, A. S.; Kelly, Deirdre A.; Maher, Eamonn R.; Gissen, Paul.

In: Human Mutation, Vol. 30, No. 2, 01.02.2009.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Molecular investigations to improve diagnostic accuracy in patients with ARC syndrome.

AU - Cullinane, Andrew R.

AU - Straatman-Iwanowska, Anna

AU - Seo, Jeong K.

AU - Ko, Jae S.

AU - Song, Kyung S.

AU - Gizewska, Maria

AU - Gruszfeld, Dariusz

AU - Gliwicz, Dorota

AU - Tuysuz, Beyhan

AU - Erdemir, Gulin

AU - Sougrat, Rachid

AU - Wakabayashi, Yoshiyuki

AU - Hinds, Rupert

AU - Barnicoat, Angela

AU - Mandel, Hanna

AU - Chitayat, David

AU - Fischler, Björn

AU - Garcia-Cazorla, Angels

AU - Knisely, A. S.

AU - Kelly, Deirdre A.

AU - Maher, Eamonn R.

AU - Gissen, Paul

PY - 2009/2/1

Y1 - 2009/2/1

N2 - Arthrogryposis, Renal dysfunction and Cholestasis (ARC) syndrome is a multi-system autosomal recessive disorder caused by germline mutations in VPS33B. The detection of germline VPS33B mutations removes the need for diagnostic organ biopsies (these carry a>50% risk of life-threatening haemorrhage due to platelet dysfunction); however, VPS33B mutations are not detectable in approximately 25% of patients. In order further to define the molecular basis of ARC we performed mutation analysis and mRNA and protein studies in patients with a clinical diagnosis of ARC. Here we report novel mutations in VPS33B in patients from Eastern Europe and South East Asia. One of the mutations was present in 7 unrelated Korean patients. Reduced expression of VPS33B and cellular phenotype was detected in fibroblasts from patients clinically diagnosed with ARC with and without known VPS33B mutations. One mutation-negative patient was found to have normal mRNA and protein levels. This patient's clinical condition improved and he is alive at the age of 2.5 years. Thus we show that all patients with a classical clinical course of ARC had decreased expression of VPS33B whereas normal VPS33B expression was associated with good prognosis despite initial diagnosis of ARC. (c) 2008 Wiley-Liss, Inc.

AB - Arthrogryposis, Renal dysfunction and Cholestasis (ARC) syndrome is a multi-system autosomal recessive disorder caused by germline mutations in VPS33B. The detection of germline VPS33B mutations removes the need for diagnostic organ biopsies (these carry a>50% risk of life-threatening haemorrhage due to platelet dysfunction); however, VPS33B mutations are not detectable in approximately 25% of patients. In order further to define the molecular basis of ARC we performed mutation analysis and mRNA and protein studies in patients with a clinical diagnosis of ARC. Here we report novel mutations in VPS33B in patients from Eastern Europe and South East Asia. One of the mutations was present in 7 unrelated Korean patients. Reduced expression of VPS33B and cellular phenotype was detected in fibroblasts from patients clinically diagnosed with ARC with and without known VPS33B mutations. One mutation-negative patient was found to have normal mRNA and protein levels. This patient's clinical condition improved and he is alive at the age of 2.5 years. Thus we show that all patients with a classical clinical course of ARC had decreased expression of VPS33B whereas normal VPS33B expression was associated with good prognosis despite initial diagnosis of ARC. (c) 2008 Wiley-Liss, Inc.

UR - http://www.scopus.com/inward/record.url?scp=64049109733&partnerID=8YFLogxK

U2 - 10.1002/humu.20900

DO - 10.1002/humu.20900

M3 - Article

VL - 30

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 2

ER -

Cullinane AR, Straatman-Iwanowska A, Seo JK, Ko JS, Song KS, Gizewska M et al. Molecular investigations to improve diagnostic accuracy in patients with ARC syndrome. Human Mutation. 2009 Feb 1;30(2). https://doi.org/10.1002/humu.20900